↓ Skip to main content

Dove Medical Press

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins

Overview of attention for article published in Neuropsychiatric Disease and Treatment, December 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
39 Mendeley
Title
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
Published in
Neuropsychiatric Disease and Treatment, December 2011
DOI 10.2147/ndt.s16085
Pubmed ID
Authors

Joohi Jimenez-Shahed

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 3%
Sweden 1 3%
Unknown 37 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 15%
Researcher 5 13%
Other 4 10%
Student > Bachelor 2 5%
Student > Doctoral Student 2 5%
Other 8 21%
Unknown 12 31%
Readers by discipline Count As %
Medicine and Dentistry 19 49%
Agricultural and Biological Sciences 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Unspecified 1 3%
Nursing and Health Professions 1 3%
Other 0 0%
Unknown 14 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2017.
All research outputs
#7,647,369
of 23,283,373 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,051
of 3,015 outputs
Outputs of similar age
#70,689
of 242,896 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#2
of 9 outputs
Altmetric has tracked 23,283,373 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,015 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,896 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.